Notice of NICHD's Participation in PAR-19-158 "Bioengineering Research Grants (BRG) (R01 Clinical Trail Not Allowed)"

Notice Number: NOT-HD-19-009

Key Dates
Release Date: March 28, 2019

Related Announcements
PAR-19-158

Issued by

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Purpose

The purpose of this Notice is to inform potential applicants that the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) will participate, effective immediately, in PAR-19-158, “Bioengineering Research Grants (BRG) (R01 Clinical Trail Not Allowed).”

Part 1. Overview Information

Components of Participating Organizations

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Cancer Institute (NCI)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Environmental Health Sciences (NIEHS)

National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Allergy and Infectious Diseases (NIAID)

National Institute on Aging (NIA)
National Eye Institute (NEI)

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.286; 93.399; 93.396; 93.395; 93.394; 93.393; 93.121; 93.853; 93.113; 93.866; 93.273; 93.846, 93.855, 93.867, 93.865

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

IC-Specific Interests

NICHD: Within the goals of this FOA, examples of research areas are:

  • Novel bioengineering approaches, including imaging and measurement of circulating factors, for safe, non-invasive, real time assessment of placenta development and function across pregnancy is of research interest to the PPB.
  • The MPID research interests include novel bioengineering for diagnosis, prevention, monitoring or intervention of HIV and other infectious diseases in infants, adolescent , and pregnant women.
  • The GHDB encourages the production of marketable novel or improved methods, devices, and technologies for the diagnosis, monitoring, and therapy of uterine fibroids, endometriosis, adenomyosis, benign ovarian cysts, abnormal menstrual cyclicity, reproductive tract abnormalities, female pelvic floor disorders, and gynecologic pain disorders. Applications that address surgical challenges in gynecologic surgeries or apply omics platforms to questions of gynecologic health and disease are also of interest.
  • The PTCIB would be interested in applications relevant to improving the care and outcomes of critically ill and injured children, including but not limited to, those with sepsis, respiratory failure, brain injury, severe trauma and/or multiple organ dysfunction syndrome.
  • The CDBB is interested in real time multichannel data acquisition and analysis technologies of infant/toddler/child/adolescent interactions with their environment and other people, includingdevelopment & testing of new, repurposed existing devices, and/or innovative technologies to improve the collection, analysis, and automated coding of time-linked audio, video, and physiological signal(s) recordings in real world settings.
  • PDB is interested in developing tools or approaches to improving physical measurement of children, especially infants and especially head circumference.
  • DBSVB welcomes applications for studies in animal models to identify and quantitatively assess the biophysical and biomechanical processes contributing to normal embryonic development, birth defects and tissue regeneration.
  • OPPTB is interested in any bioengineering processes that will develop devices and new drug delivery systems that will help improve treatment for children and pregnant women.
  • The IDDB is interested in new or existing technologies to improve the diagnosis, monitoring, management or delivery of interventions for metabolic or neurological conditions associated with intellectual and developmental disabilities (IDD) in children and adults and wearable technologies that can improve quality of life of a child or adult person with IDD such as activity and sleep sensors, mobility and daily functioning monitoring devices.

Research areas can be found at https://www.nichd.nih.gov/ or for a specific extramural branch check https://www.nichd.nih.gov/about/org/der/branches.

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)

Louis Quatrano, PhD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-402-4221
Email: quatranol@mail.nih.gov

Financial/Grants Management Contact(s)

Bryan S. Clark, MBA
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-435-6975
Email: clark1@mail.nih.gov

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Louis Quatrano, PhD
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Telephone: 301-402-4221
Email: quatranol@mail.nih.gov